2022
DOI: 10.1007/s00467-021-05370-8
|View full text |Cite
|
Sign up to set email alerts
|

Thrombotic microangiopathy in children

Abstract: The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ involvement. It comprises a spectrum of underlying etiologies that may differ in children and adults. In children, apart from ruling out shigatoxin-associated hemolytic uremic syndrome (HUS) and other infection-associated TMA like Streptococcus pneumoniae -HUS, rare inherited causes including complement-associated HUS, coba… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 94 publications
0
6
0
Order By: Relevance
“…HUS is characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and AKI and has an incidence of 0.4 to 0.6% in patients with pneumococcal infections. 19 The higher prevalence of HUS in our cohort may be explained by the difference in study settings, as we conducted our analysis in the setting of intensive care, which would include patients with poorer clinical conditions. Pneumococcal HUS has been classically regarded as “atypical HUS,” with Shiga-like toxin-producing Escherichia coli (STEC) being the typical and most prevalent cause of HUS; however, some studies have shown that invasive pneumococcal disease accounted for the majority of HUS in Asian populations.…”
Section: Discussionmentioning
confidence: 99%
“…HUS is characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and AKI and has an incidence of 0.4 to 0.6% in patients with pneumococcal infections. 19 The higher prevalence of HUS in our cohort may be explained by the difference in study settings, as we conducted our analysis in the setting of intensive care, which would include patients with poorer clinical conditions. Pneumococcal HUS has been classically regarded as “atypical HUS,” with Shiga-like toxin-producing Escherichia coli (STEC) being the typical and most prevalent cause of HUS; however, some studies have shown that invasive pneumococcal disease accounted for the majority of HUS in Asian populations.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment of TMA often includes complement inhibition. If an underlying cause is identified, it should be addressed as well [47,49].…”
Section: Thrombotic Microangiopathymentioning
confidence: 99%
“…Although there is a differential diagnosis for TMA following transplant, de-novo transplant-associated TMA (TA-TMA) is the most likely cause. The pathophysiology is complex and multifactorial and involves endothelial damage to the glomeruli with consequent activation of the complement cascade, leading to microthrombi [47][48][49][50]. Various triggers for TA-TMA have been identified and include viruses, rejection, ischemia-reperfusion injury and medications.…”
Section: Thrombotic Microangiopathymentioning
confidence: 99%
“…Atypical hemolytic uremic syndrome (aHUS) is a rare type of thrombotic microangiopathy (TMA) that is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury without coexisting disease [ 1 , 2 ]. It has been associated with dysregulation and overactivation of the alternative complement pathway due to genetic defects or the presence of autoantibodies that lead to vascular endothelial damage.…”
Section: Introductionmentioning
confidence: 99%